A test for breast cancer patients with possible depression
Part of Cancer, Skin clinical trials.
This study tests a new detection method for depression in people with breast cancer. It uses samples like blood, stool, and saliva to find a link between breast cancer and depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with breast cancer.
- You are between 18 and 80 years old.
- You do not have any other cancer now or in the past.
- You know that you have breast cancer.
- You are generally able to do daily activities with little help.
- You are willing to give blood, stool, and saliva samples.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for biological markers linked to anxiety and depression in people with solid tumors. It aims to better understand these emotional challenges and may lead to better support for patients.
This early-stage study tests PDC-1421 to treat moderate to severe depression in people who have cancer and have recently had treatment like chemotherapy and/or radiation. If you’re experiencing ongoing depressive symptoms, the study aims to see whether this medication is safe and helpful for your mood.
This study looks at differences in brain function in people who have had breast cancer, compared with certain people without that history. It’s testing how brain health changes after breast cancer and relates to mood, thinking, and daily functioning.
This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
This trial tests if transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, can help improve mood and treatment outcomes in breast cancer patients with mild to moderate depression who are receiving neoadjuvant chemotherapy before surgery.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.